ClinicalTrials.gg
CompletedNCT02797691Updated Aug 16, 2016

Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans

An interventional study of CaCBT and Medication/ Psychotherapy in Depression, Anxiety, sponsored by Peshawar Medical College. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-08-16.

Sponsored by Peshawar Medical College · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 82 studies in Depression with a site in Pakistan — 23 open to participants now, 29 under way, none of them phase 3. Depression · Pakistan.

Enrollment
67th of 77
40 · median 100
Started
2016
with 2 others
No phase
75 of 82
21 open now
Registered
10th of 82
by date

Among the 82 studies in Depression with a site in Pakistan, this one is the 67th largest by enrollment of the 77 interventional ones that give a count, is one of 3 that started in 2016, is one of 75 with no phase, and was the 10th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

23 of the 82 studies in Depression with a site in Pakistan are open now. Recruiting first, the newest first:

18 more — sign in →

All 23 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 82 studies in Depression with a site in Pakistan, or all of them as a file.
02

Study summary

CBT for common mental disorders has a strong evidence base in both the USA and the UK. There are wider cultural and linguistic differences between Non Pashtun and Pashtun population of Pakistan and Afghanistan and there is evidence from research to suggest that CBT might need some adaptations when working with clients from non-western background. This study, thus, aims to culturally adapt CBT for common mental disorders for Pashto speaking population in Pakistan and Afghanistan and to test the effectiveness of this adapted CBT through a small scale pilot study.

The study will be carried out using mixed methods; quantitative and qualitative. Qualitative part will consist of structured interview with a minimum of 10-15 patients; carers; and mental health professionals, respectively, using the interview questionnaires. The data will be analysed by systematic content and question analysis which will identify the emerging themes and categories. The data will then be reorganized into wider themes and categories and written for guidelines to culturally adapt therapy manual for common mental disorders.

Quantitative phase will be a RCT involving 40 patients (20 in each arm) to assess the effectiveness of a "CaCBT intervention" for Pashto speaking patients. All those who fulfill the diagnostic criteria of depressive episode or recurrent depressive disorder using ICD 10 RDC, are living near or can easily travel to the psychiatry departments in Peshawar, will be included in the study.

The intervention group of the RCT will receive CaCBT intervention in addition to the treatment as usual (TAU) while the control group receives TAU. The assessment will be carried out at base-line and at the end of therapy (8-12 weeks). Bradford Somatic Inventory (BSI), Hospital Anxiety and Depression Scale (HADS) and Brief Disability Questionnaire (BDQ)/ WHO DAS will be used to measure somatic symptoms, anxiety, depression and disability due to physical and psychological problems, respectively. Schwartz Outcome Scale will be used at follow up to measure the outcome.

03

Conditions studied

  • Depression, Anxiety

Keywords

  • Cognitive Behavior Therapy
  • Depression
  • Anxiety
  • Pashto
  • Pakistani
  • Afghan
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All those who fulfill the diagnostic criteria of Depressive episode (F32) or Recurrent depressive disorder (F33 except 33.4) or Anxiety disorder using ICD10 RDC and who live within travelling distance of the psychiatry department in Peshawar will be approached. Those patients, who have agreed to enter the study, will be assessed 2 weeks later, to fill in the baseline measures when they attend their first appointment. Patients will be asked to attend a further appointment at the end of study period and will be assessed again.

Exclusion criteria

Exclusion Criteria:

  • Excessive use of alcohol or drugs (using ICD 10 RDC for alcohol or drug abuse or dependence) significant cognitive impairment (for example learning disability or dementia) and active psychosis.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    CaCBT plus Treatment As Usual

    Receiving "CaCBT intervention" in addition to the Treatment as usual

    Other: CaCBT · Other: Medication/ Psychotherapy

  • Active comparator
    Treatment As Usual (TAU)

    Receiving Treatment as usual

    Other: Medication/ Psychotherapy

Interventions

  • OtherCaCBT

    Culturally Adapted Cognitive Behaviour Therapy

  • OtherMedication/ Psychotherapy

    Medication/ Psychotherapy used as usual

06

What researchers measure

Primary outcomes

  1. Change in score of Hospital Anxiety and Depression Scale (HADS) from baseline to end of therapy

    At baseline and after end of therapy \[after 6 Weekly Sessions (in almost 8 weeks time)\]

    Time frame: 2 Months

Secondary outcomes

  1. Change in score of Bradford Somatic Inventory (BSI) from baseline to end of therapy

    At baseline and after end of therapy \[after 6 Weekly Sessions (in almost 8 weeks time)\]

    Time frame: 2 Months

  2. Change in score of Brief Disability Questionnaire/ WHO DAS from baseline to end of therapy

    At baseline and after end of therapy \[after 6 Weekly Sessions (in almost 8 weeks time)\]

    Time frame: 2 Months

Other outcomes

  1. Schwartz Outcome Scale

    At end of therapy

    Time frame: 2 Months

07

Study locations

1 site
  • PRIME Foundation/ Lady Reading Hospital
    Peshawar, Khyber Pakhtunkhwa 25000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2016, a primary completion of Jul 2016 and a completion of Jul 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2016
First posted
Jun 13, 2016
Start
Jan 2016
Primary completionActual
Jul 2016
CompletionActual
Jul 2016
Last update
Aug 16, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02797691
Lead sponsor
Peshawar Medical College
Responsible party
Muhammad Irfan (Head, Department of Mental Health, Psychiatry and Behavioural Sciences, Peshawar Medical College) — Principal investigator
First posted
Jun 13, 2016
Start date
Jan 2016
Primary completion
Jul 2016
Completion
Jul 2016
Last update
Aug 16, 2016

Study contacts

Muhammad Irfan, MCPS FCPS MS
principal investigator · Peshawar Medical College

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion